All Stories

  1. A serologic weak D expressed by a combined weak D type 1/41.0.1 allele

    Article • Transfusion, May 2026, Wiley

    Gregory Denomme

  2. International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Gothenburg, Barcelona and four virtual business meetings: Update on blood group systems

    Article • Vox Sanguinis, December 2025, Wiley

    Gregory Denomme

  3. Why auto‐anti‐D might be more likely than allo‐anti‐D for people with conventional D type

    Article • British Journal of Haematology, August 2025, Wiley

    Gregory Denomme

  4. JK*01(307C) encodes a JK null allele

    Article • Transfusion, March 2025, Wiley

    Gregory Denomme

  5. Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID‐19 restriction in March 2020

    Article • Vox Sanguinis, March 2024, Wiley

    Gregory Denomme

  6. International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: Update on blood group systems

    Article • Vox Sanguinis, September 2022, Wiley

    Gregory Denomme

  7. A case of Tn polyagglutination discovered by an ABO blood group discrepancy

    Article • Transfusion, June 2022, Wiley

    Gregory Denomme

  8. Molecular blood group screening in Omani blood donors

    Article • Vox Sanguinis, October 2021, Wiley

    Gregory Denomme

  9. Generation of ‘designer erythroblasts’ lacking one or more blood group systems from CRISPR/Cas9 gene‐edited human‐induced pluripotent stem cells

    Article • Journal of Cellular and Molecular Medicine, September 2021, Wiley

    Gregory Denomme

  10. Novel KEL*02N allele in Saudi Arabia encoding a Kell null (K0) phenotype

    Article • Transfusion, June 2021, Wiley

    Gregory Denomme

  11. A pair of S‐silencing single nucleotide variants cis‐linked on GYPB

    Article • Transfusion, March 2021, Wiley

    Gregory Denomme

  12. Red cell genotyping of rare blood donors: donation behaviour and data visualization

    Article • Vox Sanguinis, January 2021, Wiley

    Gregory Denomme

  13. SCAR : The high‐prevalence antigen 013.008 in the Scianna blood group system

    Article • Transfusion, October 2020, Wiley

    Gregory Denomme

  14. Predictive modeling of complex ABO glycan phenotypes by lectin microarrays

    Article • Blood Advances, August 2020, American Society of Hematology

    Gregory Denomme

  15. Anti‐D selection for D assignment among pregnant women and blood donors: impact of the Crawford antigen

    Article • Transfusion, May 2020, Wiley

    Gregory Denomme

  16. Complement activating ABO anti-A IgM/IgG act synergistically to cause erythrophagocytosis: implications among minor ABO incompatible transfusions

    Article • Journal of Translational Medicine, May 2020, Springer Science + Business Media

    Gregory Denomme

  17. Complement activating ABO IgM/IgG act synergistically to cause erythrophagocytosis: implications among minor ABO incompatible platelet transfusions

    Article • March 2020, Research Square

    Gregory Denomme

  18. It's time to phase out “serologic weak D phenotype” and resolve D types with RHD genotyping including weak D type 4

    Article • Transfusion, March 2020, Wiley

    Gregory Denomme

  19. ABO titers: harmonization and identifying clinically relevant ABO antibodies

    Article • Transfusion, March 2020, Wiley

    Gregory Denomme

  20. Fetal inheritance of GP*Mur causing severe HDFN in an unrecognized case of maternal alloimmunization

    Article • Transfusion, February 2020, Wiley

    Gregory Denomme

  21. IgG3 anti‐Kell allotypic variation results in differential antigen binding and phagocytosis

    Article • Transfusion, January 2020, Wiley

    Gregory Denomme

  22. How to use a cloud‐based search engine of a centralized donor database to identify historical antigen‐negative units in hospital inventories

    Article • Transfusion, January 2020, Wiley

    Gregory Denomme

  23. Use of a cloud‐based search engine of a centralized donor database to identify historical antigen‐negative units in hospital inventories

    Article • Transfusion, January 2020, Wiley

    Gregory Denomme

  24. Performance and reliability of a benchtop automated instrument for transfusion testing: a comparative multicenter clinical study in the US population

    Article • Transfusion, September 2019, Wiley

    Gregory Denomme

  25. Mass-scale red cell genotyping of blood donors: from data visualization to historical antigen labeling and donor recruitment

    Article • Transfusion, June 2019, Wiley

    Gregory Denomme

  26. New RHCE*ce variant allele in African descent holds 105C > T (silent) in cis to 48C in Exon 1 and 733G in Exon 5

    Article • Transfusion, April 2019, Wiley

    Gregory Denomme

  27. Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline

    Article • Transfusion, April 2018, Wiley

    Gregory Denomme

  28. Acquired red cell defects of the regulators of complement activation.

    Article • Blood Advances, October 2017, American Society of Hematology

    Gregory Denomme

  29. Trends in antigen-negative red blood cell distributions by racial or ethnic groups in the United States

    Article • Transfusion, October 2017, Wiley

    Gregory Denomme

  30. The first reported case of concurrent trimethoprim-sulfamethoxazole-induced immune hemolytic anemia and thrombocytopenia

    Article • Transfusion, September 2017, Wiley

    Yevgeniy Linnik, Gregory Denomme

  31. 2015 conference on blood group genetics in the era of precision medicine.

    Article • Therapeutic Advances in Hematology, September 2017, SAGE Publications

    Gregory Denomme

  32. How do I work up pretransfusion samples containing anti-CD38?

    Article • Transfusion, May 2017, Wiley

    Gregory Denomme

  33. Genetic background of the rare Yus and Gerbich blood group phenotypes: homologous regions of the GYPC gene contribute to deletion alleles

    Article • British Journal of Haematology, March 2017, Wiley

    Gregory Denomme

  34. Molecular characterization of three novel weak D type alleles with additional haplotype data on weak D Types 1.2 and 18

    Article • Transfusion, February 2017, Wiley

    Gregory Denomme

  35. Practical approaches and costs for provisioning safe transfusions during anti-CD38 therapy

    Article • Transfusion, February 2017, Wiley

    Gregory Denomme

  36. Cost-effectiveness of implementing molecular immunohematology

    Article • ISBT Science Series, December 2016, Wiley

    Gregory Denomme

  37. TheDAUcluster: a comparative analysis of 18RHDalleles, some forming partial D antigens

    Article • Transfusion, August 2016, Wiley

    Gregory Denomme

  38. Unusual serological findings associated with ceftriaxone-induced immune hemolytic anemia in a child with disseminated low-grade glioma

    Article • Pediatric Blood & Cancer, June 2016, Wiley

    Gregory Denomme

  39. RHCE*cE94Gencodes variable expression of c (RH4)

    Article • Transfusion, August 2015, Wiley

    Gregory Denomme

  40. Integration of red cell genotyping into the blood supply chain: a population-based study

    Article • The Lancet Haematology, July 2015, Elsevier

    Gregory Denomme

  41. Implementing mass-scale red cell genotyping at a blood center

    Article • Transfusion, June 2015, Wiley

    Gregory Denomme

  42. A multicenter study on the performance of a fully automated, walk-away high-throughput analyzer for pretransfusion testing in the US population

    Article • Transfusion, March 2015, Wiley

    Gregory Denomme

  43. Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease

    Article • Transfusion, March 2015, Wiley

    Gregory Denomme

  44. The future of red blood cell alloimmunization risk reduction

    Article • Transfusion, January 2015, Wiley

    Gregory Denomme

  45. It's time to phase inRHDgenotyping for patients with a serologic weak D phenotype

    Article • Transfusion, December 2014, Wiley

    SUMNER GERALD Sandler, Gregory Denomme

  46. RhD Specific Antibodies Are Not Detectable in HLA-DRB11501*Mice Challenged with Human RhD Positive Erythrocytes

    Article • Advances in Hematology, January 2014, Hindawi Publishing Corporation

    Gregory Denomme

  47. Prospects for the provision of genotyped blood for transfusion

    Article • British Journal of Haematology, July 2013, Wiley

    Gregory Denomme

  48. Antibody‐mediated glycophorin C coligation on K562 cells induces phosphatidylserine exposure and cell death in an atypical apoptotic process

    Article • Transfusion, December 2012, Wiley

    Gregory Denomme

  49. Allo- and autoanti-D in weak D types and in partial D

    Article • Transfusion, September 2012, Wiley

    Gregory Denomme

  50. Microfluidic approach to genotyping human platelet antigens

    Article • IET Nanobiotechnology, January 2012, the Institution of Engineering and Technology (the IET)

    Gregory Denomme

  51. Mass-scale high-throughput multiplex polymerase chain reaction for human platelet antigen single-nucleotide polymorphisms screening of apheresis platelet donors

    Article • Transfusion, March 2011, Wiley

    Gregory Denomme

  52. DNA-based methods in the immunohematology reference laboratory

    Article • Transfusion and Apheresis Science, February 2011, Elsevier

    Gregory Denomme

  53. Editorial Comment

    Article • Transfusion and Apheresis Science, February 2011, Elsevier

    Gregory Denomme

  54. Molecular basis of blood group expression

    Article • Transfusion and Apheresis Science, February 2011, Elsevier

    Gregory Denomme

  55. Mass-scale red cell genotyping of blood donors

    Article • Transfusion and Apheresis Science, February 2011, Elsevier

    Gregory Denomme

  56. Titers of ABO antibodies in group O blood donors

    Article • Revista Brasileira de Hematologia e Hemoterapia, January 2011, Revista Brasileira de Hematologia e Hemoterapia (RBHH)

    Gregory Denomme

  57. Anti-glycophorin C induces mitochondrial membrane depolarization and a loss of extracellular regulated kinase 1/2 protein kinase activity that is prevented by pretreatment with cytochalasin D: implications for hemolytic disease of the fetus and newborn ca

    Article • Transfusion, April 2010, Wiley

    Gregory Denomme

  58. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn: what can we learn from rodent models?

    Article • Current Opinion in Hematology, November 2009, Wolters Kluwer Health

    Gregory Denomme

  59. The proximal cis-regulatory region of theRHD/RHCEpromoter is 105 bp and contains a 55-bp core devoid of known binding motifs but necessary for transcription

    Article • Transfusion, July 2009, Wiley

    Gregory Denomme

  60. Genotyping for red blood cell polymorphisms

    Article • Vox Sanguinis, February 2009, Wiley

    Gregory Denomme

  61. Single Base Extension in Multiplex Blood Group Genotyping

    Article • January 2009, Springer Science + Business Media

    Gregory Denomme

  62. Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time

    Article • Transfusion, November 2008, Wiley

    Gregory Denomme

  63. Hemolytic Disease of the Fetus and Newborn Due to Anti-Ge3: Combined Antibody-Dependent Hemolysis and Erythroid Precursor Cell Growth Inhibition

    Article • American Journal of Perinatology, August 2008, Thieme Publishing Group

    Gregory Denomme

  64. IFN-γ treated monocyte/macrophage phagocytosis of red cells sensitized with IgG1 and IgG3 Anti-D containing identical immunoglobulin variable region genes

    Article • Transfusion and Apheresis Science, August 2008, Elsevier

    Gregory Denomme

  65. The Development of a Bacteriophage Expression Vector for Cloning Immunoglobulin Variable Region Genes from B-Cell Genomic DNAa

    Article • Annals of the New York Academy of Sciences, June 2008, Wiley

    Gregory Denomme

  66. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques

    Article • Transfusion, March 2008, Wiley

    Gregory Denomme

  67. On the Complexity of D Antigen Typing: A Handy Decision Tree in the Age of Molecular Blood Group Diagnostics

    Article • Journal of Obstetrics and Gynaecology Canada, September 2007, Elsevier

    Gregory Denomme

  68. Fetal blood group genotyping

    Article • Transfusion, July 2007, Wiley

    Gregory Denomme

  69. Small world – Advance of microarrays: Current status and future trends

    Article • Transfusion and Apheresis Science, April 2007, Elsevier

    Gregory Denomme

  70. The above letter was sent to Branch et al.; Drs Branch and Denomme offered the following reply.

    Article • Transfusion, January 2007, Wiley

    Gregory Denomme

  71. Predictive blood group genetics in hemolytic disease of the fetus and newborn: a 10-year review of a laboratory evaluation of amniotic fluid-derived DNA

    Article • Prenatal Diagnosis, January 2007, Wiley

    Gregory Denomme

  72. Detection of antibodies reacting with the antithetical duffy blood group antigens Fya and Fyb using recombinant fusion proteins containing the duffy extracellular domain

    Article • Transfusion and Apheresis Science, December 2006, Elsevier

    Gregory Denomme

  73. Antenatal administration of Rh-immune globulin causes significant increases in the immunomodulatory cytokines transforming growth factor-β and prostaglandin E2

    Article • Transfusion, August 2006, Wiley

    Gregory Denomme

  74. Inhibition of erythroid progenitor cell growth by anti-Ge3

    Article • British Journal of Haematology, May 2006, Wiley

    Gregory Denomme

  75. Amino-acid substitution in the disordered loop of blood group B-glycosyltransferase enzyme causes weak B phenotype

    Article • Transfusion, July 2005, Wiley

    Gregory Denomme

  76. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes

    Article • Transfusion, May 2005, Wiley

    Gregory Denomme

  77. Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cells

    Article • Transfusion, March 2005, Wiley

    Gregory Denomme

  78. ABO sequence analysis in a family with weak expression of blood group B

    Article • Transfusion, September 2004, Wiley

    Gregory Denomme

  79. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17

    Article • Transfusion, September 2004, Wiley

    Gregory Denomme

  80. Acute intravascular hemolysis after the infusion of a chimeric red blood cell unit

    Article • Transfusion, July 2004, Wiley

    Gregory Denomme

  81. The structure and function of the molecules that carry human red blood cell and platelet antigens☆

    Article • Transfusion Medicine Reviews, July 2004, Elsevier

    Gregory Denomme

  82. A simple and rapid competitive enzyme-linked immunosorbent assay to identify HPA-1a (PlA1)-negative donor platelet units

    Article • Transfusion, February 2003, Wiley

    Gregory Denomme

  83. Fcγ receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura

    Article • British Journal of Haematology, December 2002, Wiley

    Gregory Denomme

  84. Novel 3' Rhesus box sequences confound RHD zygosity assignment

    Article • Transfusion, May 2002, Wiley

    Gregory Denomme

  85. Synonymous nucleotide substitutions in the neonatal Fc receptor

    Article • Immunogenetics, May 2002, Springer Science + Business Media

    Gregory Denomme

  86. RhD status of a fetus at risk for haemolytic disease with a discrepant maternal DNA-based RhD genotype

    Article • Prenatal Diagnosis, May 1999, Wiley

    Gregory Denomme

  87. An Adenine Trimer Precedes a C/G Polymorphism in the 3′-Amplimer Region of the Human Platelet Glycoprotein IIIa Intron 6 CT Repeat

    Article • Human Heredity, February 1998, Karger Publishers

    Gregory Denomme

  88. Activation of platelets by sera containing igg1 heparin-dependent antibodies: an explanation for the predominance of the Fcγrlla “low responder” (his131) gene in patients with heparin-induced thrombocytopenia

    Article • Journal of Laboratory and Clinical Medicine, September 1997, Elsevier

    Gregory Denomme

  89. Maternal immunization to Gov system alloantigens on human platelets

    Article • Transfusion, August 1997, Wiley

    Gregory Denomme

  90. A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry

    Article • British Journal of Haematology, December 1996, Wiley

    Gregory Denomme

  91. The prenatal identification of fetal compatibility in neonatal alloimmune thrombocytopenia using amniotic fluid and variable number of tandem repeat (VNTR) analysis

    Article • British Journal of Haematology, November 1995, Wiley

    Gregory Denomme

  92. The cDNA Sequence of Human Endothelial Cell Multimerin

    Article • Journal of Biological Chemistry, August 1995, American Society for Biochemistry & Molecular Biology (ASBMB)

    Gregory Denomme

  93. The role of the immunoglobulin heavy chain in human anti-dna antibody binding specificity

    Article • Arthritis & Rheumatism, March 1995, Wiley

    Gregory Denomme

  94. Immunoglobulin V Sequences of Two Human Antiplatelet Monoclonal Autoantibodies Derived from B Cells of Normal Origin

    Article • Journal of Autoimmunity, August 1994, Elsevier

    Gregory Denomme

  95. Immunoglobulin V region heavy and light chain gene sequences of the lymphoblastoid cell line GM 4672

    Article • Human Antibodies, September 1993, IOS Press

    Gregory Denomme

  96. The production of human monoclonal antiplatelet auto-antibodies derived from human lymphocytes of normal origin: reactivity to DNA, anionic phospholipids and platelet proteins

    Article • British Journal of Haematology, September 1992, Wiley

    Gregory Denomme

  97. Comparison of the measurement of surface or total platelet-associated IgG in the diagnosis of immune thrombocytopenia

    Article • American Journal of Hematology, January 1985, Wiley

    Gregory Denomme

  98. The production of platelet controls for assays quantitating platelet- associated IgG

    Article • Transfusion, November 1983, Wiley

    Gregory Denomme

  99. Immune-mediated thrombocytopenia of malaria.

    Article • Journal of Clinical Investigation, April 1983, American Society for Clinical Investigation

    Gregory Denomme

  100. The Measurement of Plateiet-Associated IgG Using an Immunoradiometric Assay

    Article • Journal of Immunoassay, January 1983, Taylor & Francis

    Gregory Denomme